Literature DB >> 3523136

Determination of the true immunoreactive fraction of monoclonal antibodies after radiolabeling.

T Lindmo, P A Bunn.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3523136     DOI： 10.1016/0076-6879(86)21067-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  39 in total

1.  Discordance in lymphoid tissue recovery following stem cell transplantation in rhesus macaques: an in vivo imaging study.

Authors:  Robert E Donahue; Sharat Srinivasula; Naoya Uchida; Insook Kim; Alexis St Claire; Gorka Duralde; Paula DeGrange; Marisa St Claire; Richard C Reba; Aylin C Bonifacino; Allen E Krouse; Mark E Metzger; Chang H Paik; H Clifford Lane; John F Tisdale; Michele Di Mascio
Journal:  Blood       Date:  2015-10-22       Impact factor: 22.113

2.  Carcinomatous meningitis: antibody-guided therapy with I-131 HMFG1.

Authors:  R P Moseley; J C Benjamin; R D Ashpole; N M Sullivan; J A Bullimore; H B Coakham; J T Kemshead
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

3.  In vivo imaging of rat lymphocytes with an indium 111-labelled anti-T cell monoclonal antibody: a comparison with indium 111-labelled lymphocytes.

Authors:  I Loutfi; P M Chisholm; D Bevan; J P Lavender
Journal:  Eur J Nucl Med       Date:  1990

4.  Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.

Authors:  M A Stalteri; S J Mather
Journal:  Eur J Nucl Med       Date:  1996-02

5.  Labelling monoclonal antibodies with yttrium-90.

Authors:  S J Mather; D M Tolley; G W White
Journal:  Eur J Nucl Med       Date:  1989

6.  The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies.

Authors:  Brian M Zeglis; Jason S Lewis
Journal:  J Vis Exp       Date:  2015-02-12       Impact factor: 1.355

7.  Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody.

Authors:  In Soo Shin; Sang-Myung Lee; Hyung Sub Kim; Zhengsheng Yao; Celeste Regino; Noriko Sato; Kenneth T Cheng; Raffit Hassan; Melissa F Campo; Earl F Albone; Peter L Choyke; Ira Pastan; Chang H Paik
Journal:  Nucl Med Biol       Date:  2011-07-07       Impact factor: 2.408

8.  Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer.

Authors:  Jason S Lewis; Wolfgang A Weber; Christian Lohrmann; Eileen M O'Reilly; Joseph A O'Donoghue; Neeta Pandit-Taskar; Jorge A Carrasquillo; Serge K Lyashchenko; Shutian Ruan; Rebecca Teng; Wolfgang Scholz; Paul W Maffuid
Journal:  Clin Cancer Res       Date:  2019-09-20       Impact factor: 12.531

9.  Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.

Authors:  Peter M Smith-Jones; Neeta Pandit-Taskar; Wei Cao; Joseph O'Donoghue; Martin D Philips; Jorge Carrasquillo; Jason A Konner; Lloyd J Old; Steven M Larson
Journal:  Nucl Med Biol       Date:  2008-04       Impact factor: 2.408

10.  Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry.

Authors:  Brian M Zeglis; Charles B Davis; Robert Aggeler; Hee Chol Kang; Aimei Chen; Brian J Agnew; Jason S Lewis
Journal:  Bioconjug Chem       Date:  2013-05-30       Impact factor: 4.774
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.